Sfoglia per Titolo
TUMORI MAMMARI IN GRAVIDANZA: Studio Monocentrico di Popolazione
2011-01-01 Rossi, G; Zago, G; Evangelista, L; Michieletto, S; Grigoletto, R; Valente, S; Gnoccato, B; Bozza, F; Ghiotto, C.
Tumori misti endocrino-esocrini del tratto gastrointestinale
1999-01-01 Capella, CARLO RENATO; LA ROSA, Stefano; Uccella, Silvia; Billo, P; Cornaggia, M.
Tumori neuroendocrini
2001-01-01 Carnaghi, C; Rimassa, L; Garassino, I
Tumori ossei
2004-01-01 De santis, Maria
Tumors of the body and tail of the pancreas
2000-01-01 Di Carlo, V; Zerbi, A; Balzano, G; Parisi, V
Tumour burden score and immune???related hepatotoxicity in patients with hepatocellular carcinoma or liver metastases treated with immune checkpoint inhibitors
2022-01-01 Di Carlo, Eleonora; D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Bozzarelli, Silvia; Ferrillo, Giuseppe; Vatteroni, Giulia; Pedicini, Vittorio; Giordano, Laura; Personeni, Nicola; Rimassa, Lorenza
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
2012-01-01 Casazza, A; Kigel, B; Maione, F; Capparuccia, L; Kessler, O; Giraudo, E; Mazzone, M; Neufeld, G; Tamagnone, L
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
2012-01-01 Casazza, Andrea; Kigel, B; Maione, Federica; Capparuccia, Lorena; Kessler, O; Giraudo, Enrico; Mazzone, M; Neufeld, G; Tamagnone, Luca
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
2016-01-01 Thienpont, B.; Steinbacher, J.; Zhao, H.; D'Anna, F.; Kuchnio, A.; Ploumakis, A.; Ghesquiere, B.; Van Dyck, L.; Boeckx, B.; Schoonjans, L.; Hermans, E.; Amant, F.; Kristensen, V. N.; Koh, K. P.; Mazzone, M.; Coleman, M. L.; Carell, T.; Carmeliet, P.; Lambrechts, D.
Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts
1992-01-01 Tagliabue, G.; Citti, L.; Massazza, G.; Damia, G.; Giavazzi, R.; D'Incalci, M.
Tumour Marker and FDG PET/CT for Prediction of Disease Relapse in Patients with Breast Cancer
2011-01-01 Evangelista, L; Baretta, Z; Vinante, L; Cervino, Ar; Gregianin, M; Ghiotto, C; Saladini, G; Sotti, G.
Tumour marker guided Positron Emission Tomography in Breast Cancer patients: A recipe for a perfect wedding. A systematic literature review & meta-analysis
2012-01-01 Evangelista, L; Cervino, Ar; Ghiotto, C; Al-Nahas, A; Rubello, D; Muzzio, Pc.
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer
2011-01-01 Evangelista, L.; Baretta, Z.; Vinante, L.; Cervino, A. R.; Gregianin, M.; Ghiotto, C.; Saladini, G.; Sotti, G.
Tumour Markers and Medical Imaging Devices: what is the prognostic significant in long-term follow-up?
2010-01-01 Evangelista, L; Cervino, Ar; Gregianin, M; Vinante, L; Saladini, G; Sotti, G.
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab
2007-01-01 Hassan, Cesare; Ierardi, E; Burattini, O; De Francesco, V; Zullo, A; Stoppino, G; Panella, C; Morini, S.
Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula
2006-01-01 Hassan, Cesare; Zullo, A; Ierardi, E; Burattini, O; De Francesco, V; Morini, S.
Tumour necrosis factor alpha in segmental colitis associated with diverticula
2008-01-01 Ierardi, E; Meucci, G; Hassan, Cesare; Zullo, A; Imperiali, G; De Francesco, V; Panella, C; Morini, S; Minoli, G.
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
2016-01-01 Porter, Duncan; van Melckebeke, Jurgen; Dale, James; Martina Messow, C; Mcconnachie, Alexander; Walker, Andrew; Munro, Robin; Mclaren, John; Mcrorie, Euan; Packham, Jon; D Buckley, Christopher; Harvie, John; Taylor, Peter; Choy, Ernest; Pitzalis, Costantino; B McInnes, Iain
Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use?
2012-01-01 Heijmen, L; Verstappen, Mchm; ter Voert, Eegw; Punt, Cja; Oyen, W; de Geus-Oei, Lf; Hermans, Jj; Heerschap, A; van Laarhoven, Hwm
Tumour-associated macrophages as treatment targets in oncology
2017-01-01 Mantovani, A.; Marchesi, F.; Malesci, A.; Laghi, L.; Allavena, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
TUMORI MAMMARI IN GRAVIDANZA: Studio Monocentrico di Popolazione | 1-gen-2011 | Rossi, G; Zago, G; Evangelista, L; Michieletto, S; Grigoletto, R; Valente, S; Gnoccato, B; Bozza, F; Ghiotto, C. | |
Tumori misti endocrino-esocrini del tratto gastrointestinale | 1-gen-1999 | Capella, CARLO RENATO; LA ROSA, Stefano; Uccella, Silvia; Billo, P; Cornaggia, M. | |
Tumori neuroendocrini | 1-gen-2001 | Carnaghi, C; Rimassa, L; Garassino, I | |
Tumori ossei | 1-gen-2004 | De santis, Maria | |
Tumors of the body and tail of the pancreas | 1-gen-2000 | Di Carlo, V; Zerbi, A; Balzano, G; Parisi, V | |
Tumour burden score and immune???related hepatotoxicity in patients with hepatocellular carcinoma or liver metastases treated with immune checkpoint inhibitors | 1-gen-2022 | Di Carlo, Eleonora; D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Bozzarelli, Silvia; Ferrillo, Giuseppe; Vatteroni, Giulia; Pedicini, Vittorio; Giordano, Laura; Personeni, Nicola; Rimassa, Lorenza | |
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform | 1-gen-2012 | Casazza, A; Kigel, B; Maione, F; Capparuccia, L; Kessler, O; Giraudo, E; Mazzone, M; Neufeld, G; Tamagnone, L | |
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform | 1-gen-2012 | Casazza, Andrea; Kigel, B; Maione, Federica; Capparuccia, Lorena; Kessler, O; Giraudo, Enrico; Mazzone, M; Neufeld, G; Tamagnone, Luca | |
Tumour hypoxia causes DNA hypermethylation by reducing TET activity | 1-gen-2016 | Thienpont, B.; Steinbacher, J.; Zhao, H.; D'Anna, F.; Kuchnio, A.; Ploumakis, A.; Ghesquiere, B.; Van Dyck, L.; Boeckx, B.; Schoonjans, L.; Hermans, E.; Amant, F.; Kristensen, V. N.; Koh, K. P.; Mazzone, M.; Coleman, M. L.; Carell, T.; Carmeliet, P.; Lambrechts, D. | |
Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts | 1-gen-1992 | Tagliabue, G.; Citti, L.; Massazza, G.; Damia, G.; Giavazzi, R.; D'Incalci, M. | |
Tumour Marker and FDG PET/CT for Prediction of Disease Relapse in Patients with Breast Cancer | 1-gen-2011 | Evangelista, L; Baretta, Z; Vinante, L; Cervino, Ar; Gregianin, M; Ghiotto, C; Saladini, G; Sotti, G. | |
Tumour marker guided Positron Emission Tomography in Breast Cancer patients: A recipe for a perfect wedding. A systematic literature review & meta-analysis | 1-gen-2012 | Evangelista, L; Cervino, Ar; Ghiotto, C; Al-Nahas, A; Rubello, D; Muzzio, Pc. | |
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer | 1-gen-2011 | Evangelista, L.; Baretta, Z.; Vinante, L.; Cervino, A. R.; Gregianin, M.; Ghiotto, C.; Saladini, G.; Sotti, G. | |
Tumour Markers and Medical Imaging Devices: what is the prognostic significant in long-term follow-up? | 1-gen-2010 | Evangelista, L; Cervino, Ar; Gregianin, M; Vinante, L; Saladini, G; Sotti, G. | |
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab | 1-gen-2007 | Hassan, Cesare; Ierardi, E; Burattini, O; De Francesco, V; Zullo, A; Stoppino, G; Panella, C; Morini, S. | |
Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula | 1-gen-2006 | Hassan, Cesare; Zullo, A; Ierardi, E; Burattini, O; De Francesco, V; Morini, S. | |
Tumour necrosis factor alpha in segmental colitis associated with diverticula | 1-gen-2008 | Ierardi, E; Meucci, G; Hassan, Cesare; Zullo, A; Imperiali, G; De Francesco, V; Panella, C; Morini, S; Minoli, G. | |
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial | 1-gen-2016 | Porter, Duncan; van Melckebeke, Jurgen; Dale, James; Martina Messow, C; Mcconnachie, Alexander; Walker, Andrew; Munro, Robin; Mclaren, John; Mcrorie, Euan; Packham, Jon; D Buckley, Christopher; Harvie, John; Taylor, Peter; Choy, Ernest; Pitzalis, Costantino; B McInnes, Iain | |
Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use? | 1-gen-2012 | Heijmen, L; Verstappen, Mchm; ter Voert, Eegw; Punt, Cja; Oyen, W; de Geus-Oei, Lf; Hermans, Jj; Heerschap, A; van Laarhoven, Hwm | |
Tumour-associated macrophages as treatment targets in oncology | 1-gen-2017 | Mantovani, A.; Marchesi, F.; Malesci, A.; Laghi, L.; Allavena, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile